JN
Jupiter NeurosciencesClinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform targeting neuroinflammation, mitochondrial dysfunction, and longevity indications including Parkinson's and Alzheimer's disease.
1 Pulse story
ST
Scribe TherapeuticsClinical-stage biotech developing CRISPR-based gene-editing therapeutics using its proprietary CasX enzyme platform.
5 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
—
Founded
2018
Jupiter, Florida
HQ
Alameda, California
Public (JUNS)
Status
Public (SCTX)
Jupiter Neurosciences investors
No investors on record.
Scribe Therapeutics investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for Jupiter Neurosciences and Scribe Therapeutics.